145 related articles for article (PubMed ID: 6384568)
1. Acute effect of atenolol on hemodynamic, plasma renin activity and plasma aldosterone concentration in the once daily oral administration.
Sasaki Y; Arakawa K
Jpn Circ J; 1984 Sep; 48(9):988-93. PubMed ID: 6384568
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
Man in't Veld AJ; Schalekamp MA
Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
[TBL] [Abstract][Full Text] [Related]
3. Effects of a single administration of captopril on hemodynamics and serum angiotensin converting enzyme activity, plasma renin activity and plasma aldosterone concentration in hypertensive patients.
Hashimoto H; Hiwada K; Kokubu T
Jpn Circ J; 1981 Feb; 45(2):176-80. PubMed ID: 6262543
[TBL] [Abstract][Full Text] [Related]
4. Short-term systemic hemodynamic adaptation to beta-adrenergic inhibition with atenolol in hypertensive patients.
Simon G; Franciosa JA; Gimenez HJ; Cohn JN
Hypertension; 1981; 3(2):262-8. PubMed ID: 6111532
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic and endocrine changes associated with hypotensive action of amosulalol in essential hypertension.
Ando K; Noda H; Ogata E; Fujita T
J Cardiovasc Pharmacol; 1992 Jul; 20(1):7-10. PubMed ID: 1383633
[TBL] [Abstract][Full Text] [Related]
6. Atenolol administered once daily in primary hypertension. Effects on blood pressure in relation to pre-treatment plasma renin activity.
Nilsson OR; Karlberg BE; Ohlsson O; Thulin T; Tolagen K
Acta Med Scand; 1979; 206(4):303-8. PubMed ID: 506802
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamics, biochemical and reflexive changes produced by atenolol in hypertension.
Dreslinski GR; Messerli FH; Dunn FG; Suarez DH; Reisin E; Frohlich ED
Circulation; 1982 Jun; 65(7):1365-8. PubMed ID: 6122514
[TBL] [Abstract][Full Text] [Related]
8. Enalapril and atenolol in essential hypertension: attenuation of hypotensive effects in combination.
Wing LM; Chalmers JP; West MJ; Russell AE; Morris MJ; Cain MD; Bune AJ; Southgate DO
Clin Exp Hypertens A; 1988; 10(1):119-33. PubMed ID: 2832102
[TBL] [Abstract][Full Text] [Related]
9. Predictability of antihypertensive efficacy of selective beta 1 blockers.
Volpe M; Trimarco B; Ricciardelli B; Cuocolo A; Veniero AM; De Luca N; Condorelli M
Clin Pharmacol Ther; 1983 Dec; 34(6):758-63. PubMed ID: 6641091
[TBL] [Abstract][Full Text] [Related]
10. Time-course of the anti-hypertensive action of atenolol: comparison of response to first dose and to maintained oral administration.
Leonetti G; Terzoli L; Bianchini C; Sala C; Zanchetti A
Eur J Clin Pharmacol; 1980 Nov; 18(5):365-74. PubMed ID: 7002567
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of antihypertensive effect of atenolol in patients with borderline hypertension during short-term treatment. A comprehensive study.
Imai Y; Abe K; Sato M; Kasai Y; Sato K; Omata K; Sasaki S; Nihei M; Sekino H; Yoshinaga K
Arzneimittelforschung; 1986 May; 36(5):869-73. PubMed ID: 3730023
[TBL] [Abstract][Full Text] [Related]
12. Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.
Lund-Johansen P
Br J Clin Pharmacol; 1976 Jun; 3(3):445-51. PubMed ID: 973971
[TBL] [Abstract][Full Text] [Related]
13. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
Sassard J; Zech PY; Pozet N; Cuisinaud G; Vincent M
J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
[TBL] [Abstract][Full Text] [Related]
15. Relationship of plasma renin activity and aldosterone levels with hemodynamic functions in essential hypertension.
London GM; Safar ME; Weiss YA; Corvol PL; Menard JE; Simon AC; Milliez PL
Arch Intern Med; 1977 Aug; 137(8):1042-7. PubMed ID: 327963
[TBL] [Abstract][Full Text] [Related]
16. Effect of atenolol, a new cardioselective beta-blocker, on plasma renin activity in treatment of hypertension.
Balansard P; Chabrillat Y; Paulin R; Libes M; Gérard R
Acta Cardiol; 1977; 32(4):229-43. PubMed ID: 304291
[TBL] [Abstract][Full Text] [Related]
17. Sympathetic responsiveness and antihypertensive effect of beta-receptor blockade in essential hypertension.
Distler A; Keim HJ; Cordes U; Philipp T; Wolff HP
Am J Med; 1978 Mar; 64(3):446-51. PubMed ID: 25017
[TBL] [Abstract][Full Text] [Related]
18. Effect of sotalol on haemodynamics and renin-angiotensin-aldosterone system in hypertensive patients.
Verniory A; Staroukine M; Delwiche F; Telerman M
Clin Sci Mol Med; 1976 Jul; 51(1):9-17. PubMed ID: 939070
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the cardiac and hemodynamic effects of lisinopril and atenolol in patients with hypertension: therapeutic implications.
Zusman RM; Christensen DM; Higgins J; Boucher CA
J Cardiovasc Pharmacol; 1992 Aug; 20(2):216-22. PubMed ID: 1381012
[TBL] [Abstract][Full Text] [Related]
20. [Hemodynamics, renin and aldosterone following angiotensin II blockade and sodium chloride deficiency in hypertensive subjects].
Beyer J; Liebau G; Steiner B; Schick K; Hayduk K
Verh Dtsch Ges Kreislaufforsch; 1977; 43():212-3. PubMed ID: 613577
[No Abstract] [Full Text] [Related]
[Next] [New Search]
